Table 2.
Bivariate Analysis of Risk Factors vs Graft Success.
| Characteristic | Outcome | OR | 95% CI | P | |
|---|---|---|---|---|---|
| Failure | Success | ||||
| Demographics | |||||
| n | 6 (12.5) | 42 (87.5) | |||
| Sex | 0.51 | 0.04, 3.99 | 0.67 | ||
| Male | 2 (33) | 21 (50) | |||
| Female | 4 (67) | 21 (50) | |||
| Age (years) | 26 ± 17 | 45 ± 24 | 0.96 | 0.9, 1.0 | .09 |
| Postoperative follow-up (months) | 7.7 ± 3.3 | 8.3 ± 7.3 | 0.97 | 0.8, 1.1 | .07 |
| Medical history | |||||
| Reported PCN allergy (yes) | 1 (17) | 5 (12) | .68 | 0.06, 38.27 | 0.57 |
| History of DM (yes) | 0 (0) | 4 (9.5) | inf | 0.08, inf | 1.0 |
| History of tobacco use (no) | 6 (12.5) | 42 (87.5) | |||
| History of alcohol use (no) | 6 (12.5) | 42 (87.5) | |||
| Antibiotic administered | 0.02* | ||||
| Cephalosporin | 4 (67) | 8 (19) | - | - | |
| Penicillin type | 1 (17) | 28 (67) | 12.91 | 1.09, 709.7 | |
| Clindamycin | 1 (17) | 6 (14) | 2.84 | 0.2, 171.76 | |
| Etiology | 0.02* | ||||
| Ballistic trauma | 0 (0) | 1 (2.4) | |||
| Non-ballistic trauma | 1 (17) | 6 (14) | |||
| Benign tumor | 2 (33) | 8 (19) | |||
| Odontogenic cyst | 0 (0) | 14 (33) | |||
| Osteomyelitis/MRONJ | 1 (17) | 2 (4.8) | |||
| Corrective bone surgery defect | 0 (0) | 10 (24) | |||
| Cleft maxilla | 2 (33) | 1 (2.4) | |||
| Infection during graft | 0.254 | ||||
| Acute | 1 (17) | 1 (2.4) | 0.15 | 0.0, 13.44 | |
| Chronic | 0 (0) | 6 (14) | inf | 0.12, inf | |
| No Infection | 5 (83) | 35 (83) | - | - | |
| Platelet rich fibrin adjunct (yes) | 4 (67) | 9 (21) | 0.14 | 0.01, 1.18 | 0.039* |
| Autograft adjunct (yes) | 4 (67) | 9 (21) | 0.14 | 0.01, 1.18 | 0.039* |
Note: Data are presented as mean ± SD for continuous data and n (%) for categorical data. Non-ballistic trauma (motor vehicle collision, assault, fall); benign tumor (ameloblastoma, myxoma, ossifying fibroma); odontogenic cyst (odontogenic keratocyst, dentigerous cyst, inflammatory cyst). Abbreviations: PCN, penicillin; DM, diabetes mellitus; MRONJ, medication-related osteonecrosis of the jaw.